A month ago, the Federal Council passed the legalization of cannabis. The new law is set to take effect in April. Today, the Federal Council addressed the issue, initially casting everything into doubt. However, the vote by the federal states did not yield a majority to refer the law to the mediation committee. This avoided a long delay or prevention of legalization. Germany's CDU and CSU parties aimed to significantly amend or entirely block the law in the mediation committee.

Stefan Fritsch, founder of Germany's largest cannabis platform, Grünhorn, who has contributed to an informed debate on medical cannabis through years of advocacy, states: "Today's decision by the federal states is another milestone paving the way for positive changes. The political sphere has sent a strong signal that it hears and respects the needs of the many thousands of patients in Germany who rely on medical cannabis."

Soon, these patients will be able to effectively treat conditions such as chronic pain, cancer, and MS without facing bureaucratic hurdles, criminalization, and stigmatization. This groundbreaking decision also signifies a tremendous boost for the cannabis industry. 

"German cannabis startups, pharmacies, wholesalers, and growers can now rely on a stable legal foundation, which not only secures their existence but also strengthens the country's economy. Germany has taken the lead and is now a pioneer in progressive cannabis policy, leaving other countries to catch up, " adds Sven-Roger von Schilling, CEO of Schurer Pharma and Kosmetik GmbH, part of the Grünhorn platform.